Loxapine

Loxapine

INDICATIONS

Loxapine (loxapine (loxapine (loxapine succinate) succinate) succinate) Capsules USP are indicated for the treatment of schizophrenia. The efficacy of loxapine (loxapine (loxapine (loxapine succinate) succinate) succinate) in schizophrenia was established in clinical studies which enrolled newly hospitalized and chronically hospitalized acutely ill schizophrenic patients as subjects.

DOSAGE AND ADMINISTRATION

Loxapine (loxapine (loxapine (loxapine succinate) succinate) succinate) Capsules USP are administered, usually in divided doses, two to four times a day. Daily dosage (in terms of base equivalents) should be adjusted to the individual patient's needs as assessed by the severity of symptoms and previous history of response to antipsychotic drugs.

Oral Administration

Initial dosage of 10 mg twice daily is recommended, although in severely disturbed patients initial dosage up to a total of 50 mg daily may be desirable. Dosage should then be increased fairly rapidly over the first seven to ten days until there is effective control of symptoms of schizophrenia. The usual therapeutic and maintenance range is 60 mg to 100 mg daily. However, as with other drugs used to treat schizophrenia, some patients respond to lower dosage and others require higher dosage for optimal benefit. Daily dosage higher than 250 mg is not recommended.

Maintenance Therapy

For maintenance therapy, dosage should be reduced to the lowest level compatible with symptom control; many patients have been maintained satisfactorily at dosages in the range of 20 to 60 mg daily.

HOW SUPPLIED

Loxapine (loxapine (loxapine (loxapine succinate) succinate) succinate) Capsules USP are available in the following strengths:

Loxapine (loxapine (loxapine (loxapine succinate) succinate) succinate) Succinate 6.8 mg equivalent to 5 mg loxapine (loxapine (loxapine (loxapine succinate) succinate) succinate) , black ink, hard shell, opaque, with a white body and cap, printed with Watson 369 on one half and 5 mg on the other, are supplied in bottles of 100 .

Loxapine (loxapine (loxapine (loxapine succinate) succinate) succinate) Succinate 13.6 mg equivalent to 10 mg loxapine (loxapine (loxapine (loxapine succinate) succinate) succinate) , black ink, hard shell, opaque, with a white body and yellow cap, printed with Watson 370 on one half and 10 mg on the other, are supplied in bottles of 100.

Loxapine (loxapine (loxapine (loxapine succinate) succinate) succinate) Succinate 34.0 mg equivalent to 25 mg loxapine (loxapine (loxapine (loxapine succinate) succinate) succinate) , black ink, hard shell, opaque, with a white body and green cap, printed with Watson 371 on one half and 25 mg on the other, are supplied in bottles of 100.

Loxapine (loxapine (loxapine (loxapine succinate) succinate) succinate) Succinate 68.1 mg equivalent to 50 mg loxapine (loxapine (loxapine (loxapine succinate) succinate) succinate) , black ink, hard shell, opaque, with a white body and blue cap, printed with Watson 372 on one half and 50 mg on the other, are supplied in bottles of 100.

Store at 20°-25°C (68°-77°F). [See USP controlled room temperature.] Dispense in a tight, child-resistant container.

Watson Laboratories, Inc. Corona, CA 92880, USA. Revised: March 2008. FDA Rev date: 12/02/02

Last reviewed on RxList: 8/19/2008
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Emotional Wellness

Get tips on therapy and treatment.

Health Resources
advertisement
advertisement
Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations